- Valves
- Delivery System
Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market size was estimated at USD Bn in 2021, growing at a CAGR of % during the forecast period 2022-2028.. Transcatheter pulmonary valve replacement is a surgical procedure carried in older children and adults with congenital heart disease and have normally at least one previous operation. These valves are delivery by hollow, thin, and long tube system that delivers the transcatheter pulmonary valve into hear without open heart surgery. Increase in the prevalence of congenital heart diseases, expansion of business by the companies in Middle east region, economic growth, and prolonged efficiency of transcatheter pulmonary valves are anticipated to propel the Middle East and Africa transcatheter pulmonary valve (TPV) therapy market over the forecast years. However, stringent regulations for product approval, lack of awareness in underdeveloped countries, and high cost of therapy may hamper the growth of the market.
Middle East And Africa Transcatheter Pulmonary Valve Tpv Therapy Market Summary
Study Period
2022 2028
Base Year
2021
CAGR
N/A
Largest Market
GCC Countries
Fastest Growing Market
N/A
Drivers And Restraints
Increase in the prevalence of congenital heart diseases is a key factor drive the growth of transcatheter pulmonary valve therapy market. Moreover, prolonged effectiveness of transcatheter valves, increase in the R&D for the innovation of newer products, and change in lifestyle leads to increase in prevalence of cardiovascular diseases are anticipated to fuel the transcatheter pulmonary valve (TPV) therapy market over the forecast period. However, stringent regulatory guidelines, low target population, high cost of therapy, and lack of skilled professionals may restrain the growth of transcatheter pulmonary valve (TPV) therapy market.
hghMiddle East Got Significant Share
Middle East and Africa Transcatheter Pulmonary Valve (TPV) Therapy Market
Geographically, Middle East and Africa transcatheter pulmonary valve (TPV) therapy market is segmented into Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa. Gulf Cooperation Council (GCC) Countries transcatheter pulmonary valve therapy market is growing at significant rate due to entry of companies into Middle East region, increase in healthcare expenditure, and rise in adoption of newer devices are anticipated to fuel the market. South Africa transcatheter pulmonary valve therapy market has a significant share due increase in awareness about transcatheter valves efficiency, rising healthcare expenditure, and rise in prevalence of congenital heart disease are bolster the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Middle East And Africa Transcatheter Pulmonary Valve Tpv Therapy Market Segmentation
product type
end user
- Hospitals
- Cardiology Clinics
- Ambulatory Surgical Centers
country
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
LOCATION
Geography
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
[urltag url='request-table-of-content']
- Venus MedTech (China)
- Inova (U.S.)
- Edward Lifesciences (U.S.)
- Medtronic Plc. (Ireland)